We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
London South East
Solo CEO re-engaging with prospective Tanzania gas stake buyers in the coming weeks #SOLO Watch Now
Share PricesRemote Monitor Share PriceRemote Monitor Share Chat
Pin to quick picksRemote Monitor Share Chat (RMS)
RMS Share Price
RMS Share
Price
RMS Share News
RMS Share
News
RMS Share Chat
RMS Share
Chat
41
RMS Share Trades
RMS Share
Trades
606
RMS Live RNS
RMS
Live RNS
RMS Information Buy RMS SharesBuy RMS SharesAdd RMS to WatchlistAdd RMS to WatchlistAdd RMS to AlertAdd RMS to AlertAdd RMS to myTerminalAdd RMS to myTerminal
Share Price Information for Remote Monitor (RMS)
London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
0.875
Bid:
0.87
Ask:
0.88
Change:
0.19 (27.74%)
Spread: 0.01 (1.15%)Open: 0.735High: 0.94Low: 0.865Yest. Close: 0.685
RMS Live PriceLast checked at 16:16:30
Share Discussion for Remote Monitor
Regular
Premium
Filters ON
View
Post Message
123
tomvisual
Posts: 1,169
Price: 0.875
No Opinion
RE: LITERAL GAMECHANGERToday 16:15
RNS
https://www.londonstockexchange.com/news-article/BRH/update-on-pharm2farm-s-covid-19-mask-project/14729767
states P2F has developed a coating for textiles which incorporates its proprietary nanoparticles to give textiles long lasting virucidal properties. The first application of this technology has been to coat a fabric layer in surgical masks and produce a certified antiviral (including COVID-19 and Influenza) mask for use by both healthcare professionals and the public.
So this technology applies not only to face masks but to TEXTILES!
How about surgical gowns??
How much did UK Government spend on 400k useless Turkisk gowns earlier this year???
https://www.theguardian.com/world/2020/may/07/government-confirms-400000-turkish-gowns-are-useless-for-nhs
https://www.dailymail.co.uk/news/article-8294955/amp/400-000-emergency-PPE-gowns-flown-UK-Turkey-USELESS-sitting-warehouse.html
https://www.express.co.uk/news/uk/1279035/coronavirus-uk-PPE-shortage-turkey-plane-covid-19-outbreak-latest-news-NHS/amp
No pricing?? Assuming £25 per gown, then is £10M reasonable for the useless shipment?
£10M! Thats around the BRH Market Cap in one shipment!!!
How much would you pay for a gown with an antiviral layer, which kills covid19??
OMG, this could be massive!!!!
Unique technology and low Market cap!!!!
What a combo!!!
BRH have some choice investments just waiting to explode!
Following the money with PPE which is needed more than ever in a pandemic!
Will be opening position in RMS Monday to add to my LTH here!
Carl's test plus unique antiviral PPE! WoW!
Test, test, test
500p plus eh? . Wow we wish, of course the words , Could , and Possibly, will dominate all prophesys. As per usual but it’s nice thought, and does no harm to dream, takes us away from the reality of lockdown. Good luck to all Holders.
Solid effort Tom! Thanks for the info!!!
Retireat49...
This is well worth a listen https://www.youtube.com/watch?v=22pS6R78DUI
See
https://www.pharm2farm.org/trials/
Ps...Retireat49....check out the various YouTube videos also.
A big thank you to Tom, I think you have even educated long standing BRH supporters...
As I said earlier, licensing the mask in the US would be a game changer for RMS.
http://news.sky.com/story/coronavirus-us-could-have-500000-covid-19-deaths-but-universal-mask-use-may-save-130000-lives-study-12112558
Roll on next week...Gla
Retireat49...
Researching, I think I will hold for gold here.
Face masks just added a new dimension to my investment here.
Will now open a position in RMS based on the fact that global disposable face mask market size exceeded a value of USD 74.90 billion in Q1 of 2020.
https://www.grandviewresearch.com/industry-analysis/disposable-face-masks-market
LTH now in BRH and shortly in RMS.
Both these have the potential to grow substantially.
Worthy of investment in a pandemic!!
Test, test, test
Phasefocus Holdings Limited
Braveheart owns 42.67 per cent. of the issued share capital of PhaseFocus.
PhaseFocus, a spin-out from the University of Sheffield, has developed a series of patented computational imaging techniques that have a wide range of applications including live cell imaging, engineering metrology and electron microscopy. The PhaseFocus Virtual Lens™ is a novel method for high fidelity quantitative imaging and microscopy. It is known in the scientific literature as "ptychography". It works equally well in both transmitted light and reflected light applications and, given suitable illumination sources and detectors, it can operate using any wavelength in the electromagnetic spectrum, as well as electron and other particle waves. The technology produces images with significantly higher contrast than other forms of imaging; it is particularly powerful for imaging transparent objects and for measuring physical properties. No focusing devices are required, so the PhaseFocus Virtual Lens is an inherently 'lensless' imaging method. There are therefore no associated lens-related aberrations or limitations. However, the method can also be integrated with conventional microscopes that already possess a variety of lenses and these can be used to provide optical or geometric flexibility, or for conventional imaging.
In June 2019, the company launched the second generation of its flagship product, Livecyte™, and shipped the first unit in August. Aimed at cancer and stem cell researchers, Livecyte continuously quantifies and compares dynamic live cell behaviour over many days. Powered by PhaseFocus's computational imaging technology, Livecyte™ produces high-contrast videos of precious human cells, without the use of fluorescent labels that can affect the behaviour of cells. Integrated analysis software uses proprietary image analysis algorithms to automatically track individual cells to unlock multi-parametric data and enable users to explore and compare cellular phenotypes under defined conditions, long-term, in micro-titre plates.
Livecyte™ combines gentle imaging, high contrast images and tangible outputs to provide users with deeper insights previously unattainable without dyes or labels. Over the last year, the company has significantly increased its distributor network to accelerate sales of Livecyte™ globally. The new Livecyte™ system represents such a significant advance over the previous generation system that over half of the company's existing Livecyte™ customers have ordered upgrades. The live cell imaging market was worth $1.8bn globally in 2018, (source: Live Cell Imaging Market by Product by MarketsandMarkets Research Private Ltd, published February 2019), and is forecast to grow at 8.9% per annum, (source: Live Cell Imaging Market by Product by MarketsandMarkets Research Private Ltd, published February 2019).
BRH seens to have made some interesting investments. Hopefully, they are now ready to bear fruit!!
Oildummy...
More on RMS/P2F
Crop nutrition: P2F has already received orders from key distributors in the UK and South Korea for its unique crop nutrition products.
P2F is specifically targeting the growing global hydroponics market where its water-soluble nutrients with high bioavailability have a clear competitive advantage.
Gyrometric Systems Limited:
Gyrometric Systems Limited ("Gyrometric"), in which the Company (BRH) owns an 18% interest, continued to make sales in its established marine drives market, having received further orders from a global leader in developing, producing and marketing innovative system solutions for marine propulsion systems. The client, Vulcan Couplings, is a market and technology leader in the development of highly flexible couplings, shaft systems and elastic mounts. The orders demonstrate commercial rollout of the Gyrometric product with a market leader and is a testament to the quality of the Gyrometric offering.
Gyrometric had expected to conduct trials for two major wind turbine manufacturers however, progress on these projects has been significantly slower than expected as the priorities of these manufacturers changed.
To reduce dependence on projects with long lead times, Gyrometric refocused its sales efforts to develop new markets, where the lead times are expected to be shorter and the opportunities more immediate. As a result, Gyrometric announced contracts with several companies including Tarmac and Clarke Energy.
In addition, the Company made new offerings, including a Universal Bearing Monitor, a Laser Sensor and the Absolute Dynamic Shaft Alignment ("ADSA") system. ADSA enables any builder or owner of large rotating equipment to install Gyrometric's equipment, use it to align the shafts initially, and then leave it in place to monitor conditions during the life of the asset, and when misalignment occurs, use it to measure and correct the shaft alignment absolutely.
The Memorandum of Understanding with Turkish company Gani Gemi Ve Is Makinalari Tic. Ltd ("Gani") is now bringing Gyrometric's products to the marine market in Turkey and neighbouring countries, where Gani is a leading installer of engines and other heavy equipment for both ship and rail industries.
Very interesting
Oildummy..
https://www.grandviewresearch.com/industry-analysis/disposable-face-masks-market
The global disposable face mask market size exceeded a value of USD 74.90 billion in Q1 of 2020 !
WoW!!
I wonder what this figure was Q2 , Q3 and will be Q4!
Face masks will be required for some time!
Even Trump wears one now!!
If P2F have one of the best face masks against covid then with the market caps being so low this could be an exciting investment at BRH and RMS!
Antiviral Face masks and a unique fast, sensitive and specific covid test!
What a combo! Just what the doctor could require!!
Test, test, test
Oildummy ...
P2F uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health.
Nanoparticles produced using P2F's patented process has been proven in several applications from medical resonance imaging, improving the yield and nutrition content of potatoes, chilli, basil to improving the bioavailability of key nutrients in the human gastrointestinal tract.
Retireat49...
The directors of Braveheart believe that by combining the two shareholdings of P2F in RMS, and thereafter retaining a significant interest in RMS, the business prospects for P2F can be more rapidly exploited and resourced thus enabling Braveheart to continue having an economic interest in P2F without the continuing requirement to fund P2F. The directors of Braveheart intend to retain the RMS Consideration Shares for the foreseeable future.
Retireat49...
Oildummy....
P2F:
Antiviral Face masks;
Huanglongbing, commonly referred to as Citrus Greening, is one of the contributing factors to the demise in citrus production; devastating citrus crops around the world. P2F is trialling its proprietary nanotechnology with citrus farms in both the UK and USA in an effort to hold the ongoing citrus greening epidemic. Preliminary studies have shown that zinc can kill off the Candidatus Liberibacter asiaticus bacteria associated with citrus greening, something unachievable with current commercial bactericides. Pharm2Farm's technology enables the zinc to be applied as drench or foliar spray to the plant, effectively and efficiently translocating the zinc to the site of infection. If successful, this new nSitu™ technology will sit alongside the P2F's growing portfolio of nano-agritech designed materials to support commercial farmers around the world.
More recently, P2F has recently installed a new manufacturing plant at MediCity in Nottingham, which has increased production capacity for the continuous production of a wide range of nano-materials that can be used for MANY applications.
https://www.grandviewresearch.com/industry-analysis/disposable-face-masks-market
RMS:
RMS has two trading subsidiaries, GyroMetric Systems Limited ("GyroMetric"), in which it owns a 58 per cent. interest (and in which Braveheart has a separate 18 per cent. interest), which develops and manufactures digital monitoring and safeguarding systems for rotating shafts and Cloudveil Limited ("Cloudveil"), an intelligence services and security risk management business, which was acquired in September 2019.
Feel free to offload at 48p. IF trials are successful and big partnerships are formed. The SP is basically going warp speed to 500p+
Maybe TB putting the best jockey on his favorite of the 6 horses?
No Idea
Each Way - bets - looking good here for both RMS and goodness me - the Paraytec test ...
Still can't work out why no news coverage.
Anyway
Happy here to hold and add - feels like a boomer - GLA and have a great Wk End.
Text, my apologies as I am somewhat confused by it all. I viewed that paraytec alone will keep us hovering around 40 to 50p. The last thing I want to do is upset you guys, I just want to understand it all
I'm feeling fairly comfortable here. But as Retire has said I'm also struggling to find the reason for TB selling to TB. Do RMS have any other golden goose I don't know about?
Isthis, that's why I asked this morning if it works like that? I would rather have had an explanation of the way it works? If its not just a simple percentage of a percentage what is it?
Can you explain the reasoning behind the sale? As share holders what do we gain? We received 12% of RMS in the form of shares (we already had 25%) If the masks are a huge success how do we benefit from the sales? Do we get a percentage of profits?
And for the record, yes I'm a novice.
Ps. By the way I didn't jump in on the spike, I topped up on the spike.
They must find bigger player to partner up, hopefully that can happen, hopefully brh is not planning on selling paraytec for peanuts, hopefully no delays or placement. Happened to SNG, small company further tests, no partner, placing, sounds like a great news for treatment but SP is diving. Comparable because its covid stock as well
The bigger picture here is obviously when rapid test is approved and ready to sell.
By xmas we should/hopefully know a timeframe and have further updates.
I've seen a few points on here regarding brh/paraytec are not big enough to manufacture and sell large amounts of tests or could struggle to get product to the market.
What do you guys/girls think?
If you see the rise to 48p you'll get the itch to wait and see if you can grab it for 50 or maybe 55 or you'll start dreaming about 100s haha greed wins most of the times
Retire - I have to say this has crossed my mind - thinking it was a strategic thing but I have no idea either in honesty.
I am new here so may be a more LTH can help out on this point?
Cheers
Not sure the purpose of your post?
If you have that much concern then you should just sell up now. If you honestly believe what you wrote then expecting a 30% increase from here to your 48p sell price wouldn't make sense, surely? why tell us all your grave concerns and finish with you will sell when we see +30% rise :-)
A very confusing email..
Thanks for sharing your views though...
TILS, dropped after excellent news and raise at 2quid, ready to blow i hope. Ncyt, a few drops around good news then sky bound, I garee CEO is far from ideal in the way he does his trades at times. But just basics, masks and tests, greening coming, it would be quite a suprise to not see this near 50p soon. But, this is aim. A fair few got caught on a spike when our CEO unloaded a bunch. Once bitten... I am happy enough but then my buys were below 30p except a cheeky trade I have running at 33p. Thought i would get out today with 38 but looks like i will wait. Perhaps until your 48p :P